Leadership & Pay ·
NovaBridge Biosciences will hold its Annual General Meeting of Shareholders on September 8, 2026, in Shanghai, China
IMABNovaBridge Biosciences
NovaBridge Biosciences will hold its Annual General Meeting of Shareholders on September 8, 2026, in Shanghai, China. The meeting's primary agenda is an ordinary resolution to remove Ms. Xin Liu from her position as a director of the Company. The Board of Directors recommends that shareholders vote in favor of this removal. NovaBridge Biosciences is a clinical-stage biopharmaceutical company advancing innovative medicines for areas of significant unmet need.